TECHNOLOGY - July 7, 1993

Scripps Altering Its Deal With Sandoz: The nation’s largest independent biomedical research institute said it is reworking a contract with the pharmaceutical company to reduce the control the Swiss drug maker will have over the research center. La Jolla-based Scripps announced the change after its proposed affiliation with Sandoz was attacked in congressional hearings as amounting to a foreign buyout. Scripps Research Institute gets about $70 million of its $120-million annual budget from federal grants. Under last year’s plan, Scripps would grant Sandoz right of first refusal to commercialize all its discoveries over 10 years.